Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndromes and Leukemia, Myeloid, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00968071
What this trial is testing

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 71
Early research (Phase 1)Study completedNCT00003693
What this trial is testing

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 30
Post-approval studies (Phase 4)Study completedNCT00487448
What this trial is testing

SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

Who this might be right for
Myelodysplastic SyndromeAcute Myeloblastic Leukemia
PETHEMA Foundation 200
Testing effectiveness (Phase 2)Ended earlyNCT02259348
What this trial is testing

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 12
Early research (Phase 1)Ended earlyNCT02231853
What this trial is testing

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Who this might be right for
Chronic Lymphocytic LeukemiaCML (Chronic Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 12
Testing effectiveness (Phase 2)Study completedNCT04942730
What this trial is testing

Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

Who this might be right for
Leukemia, Acute LymphoblasticMyeloid Leukemia, AcuteBiphenotypic Acute Leukemia+3 more
St. Petersburg State Pavlov Medical University 50
Early research (Phase 1)Study completedNCT02750995
What this trial is testing

Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Daniel El Fassi 5
Testing effectiveness (Phase 2)Study completedNCT02756572
What this trial is testing

Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms

Who this might be right for
Blasts 10 Percent or More of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia-2High Grade Malignant Neoplasm+6 more
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT01866839
What this trial is testing

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Who this might be right for
MDS (Myelodysplastic Syndrome)Myeloproliferative DisorderLymphoma, Non-Hodgkin+2 more
National Heart, Lung, and Blood Institute (NHLBI) 41
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Not applicableUnknownNCT00596999
What this trial is testing

A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

Who this might be right for
Hematologic Malignancies
Celgene Corporation 6
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT01423175
What this trial is testing

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMDS
Hannover Medical School 60
Testing effectiveness (Phase 2)Study completedNCT00274781
What this trial is testing

Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
The Cleveland Clinic 30
Early research (Phase 1)UnknownNCT01716364
What this trial is testing

Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Multiple MyelomaAcute Myeloid LeukaemiaMyelodysplastic Syndrome
Peter MacCallum Cancer Centre, Australia 6
Testing effectiveness (Phase 2)Ended earlyNCT01898793
What this trial is testing

Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 89
Early research (Phase 1)WithdrawnNCT03612739
What this trial is testing

EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2

Who this might be right for
AML, AdultMyelodysplastic Syndromes
Celyad Oncology SA
Large-scale testing (Phase 3)Study completedNCT00719563
What this trial is testing

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+7 more
Alliance for Clinical Trials in Oncology 364
Next Page